JNJ Related Trader Talk
-
Amarin's (AMRN) Vascepa Tracking Well 3-Months In; Investors Eye Tier 2 Designation
-
Warburg Said to Pick JPMorgan to Lead Massive Bausch & Lomb IPO
-
Herbalife (HLF) Has Largest Short Interest Gain on NYSE, Ford (F) Largest Drop
-
Leggett & Platt (LEG), Dividends Aristocrats and the Fiscal Cliff
-
StreetInsider.com's Stocks for an Obama Victory
-
StreetInsider.com Guide for Presidential Election Stocks
-
J&J (JNJ) on Track for Record-High Close
-
Stocks Crossing 50-Day SMA 10/15: (RF) (SNDK) (CSCO) Above; (EBAY) (DCTH) (HRS) Below
-
Edwards Lifesciences (EW) Rivals on Watch after Q3 Warning
-
Dendreon (DNDN) Takes a Downer as ZYTIGA Makes News
-
Dendreon (DNDN) Hit On Various Worries, Deutsche Bank Defends
-
Cantor Fitzgerald Maintains a 'Buy' on Warner Chilcott (WCRX); Let's Make It Official
-
Medivation (MDVN) Higher on Positive Data from J&J's Zytiga
-
Dendreon (DNDN) Smacked on Positive Data from J&J's (JNJ) Zytiga
-
Hedge Funds Outperform S&P; 15 Stocks Added To Goldman Sachs Hedge Fund VIP List
-
Traders Watching Immucor (BLUD) Rivals On Takeover
-
FDA Approves J&J's (JNJ) Zytiga; Dendreon (DNDN) Shares Volatile Following Announcement
-
Corporate Earnings for Q1 Look Promising So Far, Here's the Top Movers...
-
Pre-Open Movers 4/19: (CR) (JNJ) (GS) Higher, (BMI) (PKG) (TXN) Lower (more...)
-
Q1 Earnings Season to Begin April 11th as Alcoa (AA) Leads the Way
-
Abbott Labs (ABT) wins appeal of $1.67B Humira verdict won by J&J (JNJ) -Bloomberg
-
FDA has declined J&J's (JNJ) bid for less frequent dosing of Procrit -WSJ
-
13F from Buffett's Berkshire Shows New Stake in BK, Raised Stakes in WFC, JNJ, Lowered Stakes in PG, IR
-
Alcoa Kicks Off Q3 with Earnings on October 7, Big Names to Follow (AAPL, F, JNJ, GOOG, C, More...)
-
Traders Watching Bio-Rad (BIO) and J&J (JNJ) On Weak Immucor (BLUD) Results and Guidance
-
Paulson Sees $4,000 Gold and Says "Buy a Home"
-
Wall Street Hubbub 9/17: Meet Lisa Falcone, Radware Talks Heat Up Again, First Marblehead Gets Up
-
Vical (VICL) and GenVec (GNVC) Could See Interest on Crucell Deal News
-
S&P Announces Changes to S&P SmallCap 600 Index: MPWR for MEND
-
Tepper's Appaloosa Increases Exposure to Big Pharma, Reduces Risk in Financials (C, BAC, MRK, PFE, More...)
-
Buffett's Berkshire Nearly Doubles Stake in J&J (JNJ), Shows New Stake In Fiserv (FISV)
-
Buffett's Berkshire Hathaway Nearly Doubles Stake in J&J (JNJ), Now at ~41.32M Shares
-
Citi Says J&J (JNJ) 10-, 30-Yr Coupons at Lowest Level on Record -Bloomberg
-
Goldman Sachs' Hedge Fund VIP List (CIT, CF, ACL, GILD, more...)
-
Tepper's Appaloosa Cuts Stakes In Bank Stocks (BAC, C, WFC), Enters Pharmaceutical and Energy Stocks
-
Buffett's Berkshire Adds to Shares of IRM, RSG and BDX, Sells JNJ, KFT, PG, and Others
-
Boson Scientific (BSX) Earnings Preview: Shares Fibrillated Through Q1, Look to Restore Rhythm (STJ, MDT, JNJ)
-
Has the Market Already Downgraded U.S. Triple-A Rating?
-
Study Shows Record $65 billion Spent by U.S. Biopharmaceutical Companies in R&D
-
Palomar Medical (PMTI) Slammed After J&J Terminates Agreement On Wrinkle Treatment Laser Device
-
Elan (ELN) Issues Statement Regarding Federal Court Ruling on Tysabri Collaboration Agreement
-
FDA Warns J&J (JNJ) Over Journal Ad for Skin Cream -DJ
-
Warren Buffett raises his stake in Johnson & Johnson (JNJ) by about 4.4 million shares
-
Short Interest Falls In C, GE, WFC, CAT, WMT, IBM, T, DIS, MCD, JNJ; Rises In BAC, F, CIT, JPM, AIG
-
JNJ (NYSE: JNJ) to Buy 18.4% Stake In Elan (NYSE: ELN) for $1B
-
Dendreon (DNDN) and OncoGenex (OGXI) Could See Interest On JNJ's Cougar Biotech Deal
-
Warren Buffett Raises Stakes In Two Banks (WFC, USB), and Buys More J&J After Selling Last Qtr
-
Warren Buffett Raises his stake in Johnson & Johnson (NYSE: JNJ) after selling last quarter
-
Warren Buffett Has Worst Year Ever, In Market He's "Never Before Witnessed"
-
S&P Announces Changes to US Indices: LSTR for PSUN, ASEI for LSTR, BLUD for FBN, AVAV for BLUD, BRLI for MNT
Back to JNJ Stock Lookup
